BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 33054612)

  • 1. The inFlow intraurethral valve-pump for women with detrusor underactivity: A summary of peer-reviewed literature.
    Hartigan SM; Dmochowski RR
    J Spinal Cord Med; 2022 Jul; 45(4):489-497. PubMed ID: 33054612
    [No Abstract]   [Full Text] [Related]  

  • 2. Detrusor underactivity in women: A current understanding.
    Hartigan SM; Reynolds WS; Dmochowski RR
    Neurourol Urodyn; 2019 Nov; 38(8):2070-2076. PubMed ID: 31432566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detrusor Underactivity and the Underactive Bladder: A Systematic Review of Preclinical and Clinical Studies.
    Osman NI; Esperto F; Chapple CR
    Eur Urol; 2018 Nov; 74(5):633-643. PubMed ID: 30139634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New therapeutic directions to treat underactive bladder.
    Chai TC; Kudze T
    Investig Clin Urol; 2017 Dec; 58(Suppl 2):S99-S106. PubMed ID: 29279882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Underactive bladder, detrusor underactivity, definition, symptoms, epidemiology, etiopathogenesis, and risk factors.
    Aldamanhori R; Chapple CR
    Curr Opin Urol; 2017 May; 27(3):293-299. PubMed ID: 28221218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urodynamics criteria of detrusor underactivity in women underwent middle urethral sling for stress urinary incontinence: What is the clinical role?
    Rubilotta E; Balzarro M; Gubbiotti M; Cerrato C; Giannantoni A; Antonelli A
    Neurourol Urodyn; 2021 Nov; 40(8):1955-1965. PubMed ID: 34420231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urodynamics of men with urinary retention.
    Guo DP; Comiter CV; Elliott CS
    Int J Urol; 2017 Sep; 24(9):703-707. PubMed ID: 28687026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of neuromodulation in a novel obese-prone rat model of detrusor underactivity.
    Gonzalez EJ; Grill WM
    Am J Physiol Renal Physiol; 2017 Sep; 313(3):F815-F825. PubMed ID: 28637788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-void residual urine ratio: A novel clinical approach to the post-void residual urine in the assessment of males with lower urinary tract symptoms.
    Rubilotta E; Balzarro M; Trabacchin N; Righetti R; D'Amico A; Blaivas JG; Antonelli A
    Investig Clin Urol; 2021 Jul; 62(4):470-476. PubMed ID: 34085789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detrusor underactivity and the underactive bladder: a new clinical entity? A review of current terminology, definitions, epidemiology, aetiology, and diagnosis.
    Osman NI; Chapple CR; Abrams P; Dmochowski R; Haab F; Nitti V; Koelbl H; van Kerrebroeck P; Wein AJ
    Eur Urol; 2014 Feb; 65(2):389-98. PubMed ID: 24184024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Voiding dysfunction due to detrusor underactivity: an overview.
    Drake MJ; Williams J; Bijos DA
    Nat Rev Urol; 2014 Aug; 11(8):454-64. PubMed ID: 25002201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of clean intermittent catheterization in the treatment for detrusor underactivity.
    Méndez-Rubio S; López-Pérez E; Laso-Martín S; Vírseda-Chamorro M; Salinas-Casado J; Esteban-Fuertes M; Moreno-Sierra J
    Actas Urol Esp (Engl Ed); 2020 May; 44(4):233-238. PubMed ID: 32151472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Videourodynamic factors predictive of successful onabotulinumtoxinA urethral sphincter injection for neurogenic or non-neurogenic detrusor underactivity.
    Jiang YH; Jhang JF; Chen SF; Kuo HC
    Low Urin Tract Symptoms; 2019 Jan; 11(1):66-71. PubMed ID: 29024564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapeutic effects of sacral neuromodulation on detrusor underactivity].
    Wang Q; Zhang WY; Liu XH; Wang MR; Lai JH; Hu H; Xu T; Xu KX
    Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Aug; 53(4):671-674. PubMed ID: 34393226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of tadalafil versus silodosin on voiding function in male patients with non-neurogenic detrusor underactivity: A comparative study using propensity score matching.
    Matsukawa Y; Majima T; Funahashi Y; Fujita T; Ishida S; Kato M; Gotoh M
    Int J Urol; 2021 Apr; 28(4):411-416. PubMed ID: 33393153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Functional changes during the voiding phase in males with non-neurogenic detrusor underactivity undergoing bladder catheterization.].
    Vírseda-Chamorro M; Salinas-Casado J; Méndez-Rubio S; Barroso Manso Á; Esteban-Fuertes M
    Arch Esp Urol; 2019 Jul; 72(6):564-569. PubMed ID: 31274121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transobturator mid-urethral sling in females with stress urinary incontinence and detrusor underactivity: effect on voiding phase.
    Natale F; Illiano E; Zucchi A; Balzarro M; La Penna C; Costantini E
    Int Urogynecol J; 2019 Sep; 30(9):1519-1525. PubMed ID: 30715577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of bladder wall thickness in the evaluation of detrusor underactivity: Development of a clinical nomogram.
    De Nunzio C; Lombardo R; Cicione A; Trucchi A; Carter S; Tema G; Nacchia A; Vicentini C; Tubaro A
    Neurourol Urodyn; 2020 Apr; 39(4):1115-1123. PubMed ID: 32110842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of transurethral resection of the prostate in unobstructed patients with concomitant detrusor underactivity.
    Rubilotta E; Balzarro M; Gubbiotti M; Antonelli A
    Neurourol Urodyn; 2020 Nov; 39(8):2179-2185. PubMed ID: 32720738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics and useful signs to differentiate detrusor underactivity from bladder outlet obstruction in men with non-neurogenic lower urinary tract symptoms.
    Matsukawa Y; Yoshida M; Yamaguchi O; Takai S; Majima T; Funahashi Y; Yono M; Sekido N; Gotoh M
    Int J Urol; 2020 Jan; 27(1):47-52. PubMed ID: 31542892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.